Kaasjager KA - Search Results

1

Endothelin in renal pathophysiology: from experimental to therapeutic application.

Rabelink TJ, Kaasjager KA, Stroes ES, Koomans HA. Rabelink TJ, et al. Among authors: kaasjager ka. Kidney Int. 1996 Dec;50(6):1827-33. doi: 10.1038/ki.1996.502. Kidney Int. 1996. PMID: 8943463 Free article. Review. No abstract available.

2

Home monitoring by pulse oximetry of primary care patients with COVID-19: a pilot randomised controlled trial.

Smit K, Venekamp RP, Krol LA, Geersing GJ, Schoonhoven L, Kaasjager KA, Rutten FH, Zwart DL. Smit K, et al. Among authors: kaasjager ka. Br J Gen Pract. 2023 Apr 27;73(730):e356-e363. doi: 10.3399/BJGP.2022.0224. Print 2023 May. Br J Gen Pract. 2023. PMID: 37105736 Free PMC article. Clinical Trial.

3

Interactions of nifedipine with the renovascular effects of endothelin in humans.

Kaasjager KA, van Rijn HJ, Koomans HA, Rabelink TJ. Kaasjager KA, et al. J Pharmacol Exp Ther. 1995 Oct;275(1):306-11. J Pharmacol Exp Ther. 1995. PMID: 7562563

4

L-arginine does not prevent the renal effects of endothelin in humans.

Bijlsma JA, Rabelink AJ, Kaasjager KA, Koomans HA. Bijlsma JA, et al. Among authors: kaasjager ka. J Am Soc Nephrol. 1995 Jan;5(7):1508-16. doi: 10.1681/ASN.V571508. J Am Soc Nephrol. 1995. PMID: 7703389

5

Effectiveness of enalapril versus nifedipine to antagonize blood pressure and the renal response to endothelin in humans.

Kaasjager KA, Koomans HA, Rabelink TJ. Kaasjager KA, et al. Hypertension. 1995 Apr;25(4 Pt 1):620-5. doi: 10.1161/01.hyp.25.4.620. Hypertension. 1995. PMID: 7721406 Clinical Trial.

6

Effects of endothelin-1 on renal function in humans: implications for physiology and pathophysiology.

Rabelink TJ, Kaasjager KA, Boer P, Stroes EG, Braam B, Koomans HA. Rabelink TJ, et al. Among authors: kaasjager ka. Kidney Int. 1994 Aug;46(2):376-81. doi: 10.1038/ki.1994.284. Kidney Int. 1994. PMID: 7967349 Free article. Clinical Trial.

7

Role of endothelin receptor subtypes in the systemic and renal responses to endothelin-1 in humans.

Kaasjager KA, Shaw S, Koomans HA, Rabelink TJ. Kaasjager KA, et al. J Am Soc Nephrol. 1997 Jan;8(1):32-9. doi: 10.1681/ASN.V8132. J Am Soc Nephrol. 1997. PMID: 9013446

8

Endothelin-1-induced vasopressor responses in essential hypertension.

Kaasjager KA, Koomans HA, Rabelink TJ. Kaasjager KA, et al. Hypertension. 1997 Jul;30(1 Pt 1):15-21. doi: 10.1161/01.hyp.30.1.15. Hypertension. 1997. PMID: 9231815 Clinical Trial.

9

Multifactorial intervention with nurse practitioners does not change cardiovascular outcomes in patients with chronic kidney disease.

van Zuilen AD, Bots ML, Dulger A, van der Tweel I, van Buren M, Ten Dam MA, Kaasjager KA, Ligtenberg G, Sijpkens YW, Sluiter HE, van de Ven PJ, Vervoort G, Vleming LJ, Blankestijn PJ, Wetzels JF. van Zuilen AD, et al. Among authors: kaasjager ka. Kidney Int. 2012 Sep;82(6):710-7. doi: 10.1038/ki.2012.137. Epub 2012 Jun 27. Kidney Int. 2012. PMID: 22739979 Free article. Clinical Trial.

10

A novel clinical nomogram for the evaluation of disorders of plasma osmolality.

Voets PJGM, Vogtländer NPJ, Kaasjager KAH. Voets PJGM, et al. Clin Kidney J. 2021 Feb 10;14(6):1552-1556. doi: 10.1093/ckj/sfaa230. eCollection 2021 Jun. Clin Kidney J. 2021. PMID: 34276975 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

90 results

Search Page